This invention relates to the field of
traditional Chinese medicine preparations, and discloses a Tongli
capsule and its preparation process, comprising the following raw materials:
Eupolyphaga sinensis, processed
Arisaema heterophyllum, vinegar-processed
frankincense, vinegar-processed
myrrh, dragon bone,
Angelica dahurica,
Lysimachia christinae, safflower,
Notopterygium incisum,
Angelica sinensis,
Saposhnikovia divaricata,
Cimicifuga foetida,
Ligusticum chuanxiong, and
Acorus tatarinowii; wherein, the raw materials are dried, pulverized, mixed, and then filled into
capsule shells to form capsules. This Tongli
capsule, using a total of fourteen traditional Chinese medicines as raw materials, follows the treatment principles of
traditional Chinese medicine of dispelling wind and dampness, relaxing muscles and tendons, and promoting
blood circulation and removing
blood stasis. It has significant
efficacy for late-stage fractures and joint dislocations,
joint pain,
synovitis, and other diseases caused by wind-cold-dampness obstructing the meridians. Furthermore, the
capsule dosage form, with its uniform
fine powder contents, makes it convenient to take, provides accurate dosage, has high
bioavailability, and improves
patient compliance. Compared to decoctions, capsules do not require decocting, making them easier to carry and store; compared to pills and powders, capsules can
mask unpleasant odors of the
medicine, and disintegrate rapidly, resulting in faster
onset of action.